Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Linkoping – page 15

180 clinical trials in Linkoping, Sweden across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Linkoping at a glance
180
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

180 trials in Linkoping

Open in trial search
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Alemtuzumab
  • Sponsor:St. Anna Childrens Cancer Research Institute GmbH

Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Norwegian University Of Science And Technolology

Erectile dysfunction

Not recruiting

Study on the Safety and Effectiveness of LIB-01 for Treating Erectile Dysfunction in Adult Men

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:LIB-01 monohydrate
  • Sponsor:Dicot AB

Plasma cell myeloma

Not recruiting

Study on the Effectiveness of Ixazomib, Lenalidomide, and Dexamethasone in Treating Newly Diagnosed Multiple Myeloma in Patients Eligible for Transplant

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ixazomib
  • Sponsor:HUS-Yhtymae

Study on Ticagrelor and Acetylsalicylic Acid for Patients with Acute Coronary Syndrome Undergoing Coronary Artery Bypass Grafting

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Vaestra Goetalandsregionen

Cervix carcinoma

Not recruiting

Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer Ginecologico

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ixekizumab
  • Sponsor:NU Hospital Group-Vaestra Goetalandsregionen

Major depression

Not recruiting

Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

Investigational
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Crohn's disease

Not recruiting

Study of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AZD7798
  • Sponsor:AstraZeneca AB

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum der Universitaet Muenchen AöR

Nephropathy

Not recruiting

Study on the Effects of Povetacicept for Adults with IgA Nephropathy

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Povetacicept
  • Sponsor:Alpine Immune Sciences Inc.

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Linkoping

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Groundbreaking studies focusing on atrial fibrillation prevention and treatment of chronic kidney disease with hypertension. Research includes novel therapies for stroke prevention and innovative drug combinations for metabolic conditions.

  • Stroke Prevention Trials
  • Hypertension Management
  • Metabolic Disorders

Current studies evaluate new anticoagulants and combination therapies for better patient outcomes.

02 Oncology Studies

Comprehensive research into various cancer types, including lymphocytic leukemia, testicular cancer, and esophageal carcinoma. Studies focus on optimizing treatment sequences and exploring new therapeutic approaches.

  • Hematological Malignancies
  • Solid Tumors
  • Pediatric Oncology

Investigations include both conventional and innovative treatment strategies.

03 Neurological & Mental Health

Innovative research examining prolonged grief disorder and major depressive disorder. Studies investigate novel therapeutic approaches and hormone effects on decision-making processes.

  • Depression Treatment
  • Behavioral Studies
  • Hormone Research

Research combines pharmacological interventions with behavioral assessments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.